Hamsten A, Blombäck M, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger L
Br Heart J. 1986 Jan;55(1):58-66. doi: 10.1136/hrt.55.1.58.
Coagulation factor VIII, von Willebrand factor, antithrombin, fibrinogen, plasminogen activator capacity, and inhibitors of fibrinolysis, including a recently discovered fast inhibitor of tissue plasminogen activator, were measured three to six months after myocardial infarction in 116 male and 32 female patients aged less than 45 and in 136 age and sex matched random controls. Plasma concentrations of fibrinogen and the fast inhibitor of tissue plasminogen activator were raised in male patients (with or without correction for orosomucoid levels, blood group distribution, tobacco and alcohol consumption, and weight/height index) and plasminogen activator capacity was reduced. In female patients the concentrations of factor VIII, von Willebrand factor, the fast inhibitor of tissue plasminogen activator, alpha 2-antiplasmin, and C1 inhibitor were significantly increased. The increase in factor VIII concentrations depended strongly on a persisting inflammatory response. Multivariate analysis indicated that a combination of fibrinogen and tissue plasminogen activator inhibitor concentrations gave the best independent discrimination between male patients and controls. For female patients the best combination was von Willebrand factor and tissue plasminogen activator inhibitor. Male patients with multiple vessel atheromatosis at coronary angiography had higher fibrinogen concentrations than those with atheromatosis of a single vessel. Atheromatosis was defined as sharp-edged, plaque-like, or irregular indentations, often multiple, into the vessel lumen without features suggesting fibromuscular hyperplasia.
在116名年龄小于45岁的男性和32名年龄小于45岁的女性心肌梗死患者以及136名年龄和性别匹配的随机对照者中,于心肌梗死后三至六个月测定了凝血因子VIII、血管性血友病因子、抗凝血酶、纤维蛋白原、纤溶酶原激活剂活性以及纤维蛋白溶解抑制剂,包括最近发现的组织纤溶酶原激活剂快速抑制剂。男性患者血浆纤维蛋白原和组织纤溶酶原激活剂快速抑制剂的浓度升高(无论是否校正类黏蛋白水平、血型分布、烟酒消费及体重/身高指数),且纤溶酶原激活剂活性降低。女性患者中,因子VIII、血管性血友病因子、组织纤溶酶原激活剂快速抑制剂、α2-抗纤溶酶和C1抑制剂的浓度显著升高。因子VIII浓度的升高强烈依赖于持续的炎症反应。多变量分析表明,纤维蛋白原和组织纤溶酶原激活剂抑制剂浓度的组合对男性患者和对照者的区分能力最强。对于女性患者,最佳组合是血管性血友病因子和组织纤溶酶原激活剂抑制剂。冠状动脉造影显示有多支血管动脉粥样硬化的男性患者,其纤维蛋白原浓度高于单支血管动脉粥样硬化患者。动脉粥样硬化定义为血管腔内边缘锐利、斑块样或不规则的压痕,通常为多发,无提示纤维肌性增生的特征。